Cancer-Related Biochemical Pathways: From Tumor Outgrowth, Metastasis to Novel Targeted Therapy
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".
Deadline for manuscript submissions: 20 March 2025 | Viewed by 2593
Special Issue Editor
Interests: apoptosis; cell cycle; cell proliferation; cancer-related biochemical pathways; Myc-driven tumorigenesis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Despite the scientific achievements in the field of cancer prevention, disease management, and treatment of malignancy, the survival rates in most tumor types remain very poor. Dissecting biochemical pathways underlying the development of cancer should be given high priority to develop novel and effective therapeutic strategies. In this special issue, we invite investigators to contribute original research articles and review articles describing and discussing the various aspects of cancer-related biochemical pathways. We welcome new knowledge of the molecular alterations that deregulate signaling pathways and lead to tumor progression in human cancers. We would like to focus this Special Issue on studies that combine basic and translational research and provide deep knowledge of how a signaling pathway is involved in proliferation and/or different types of cancer cell death (apoptosis, ferroptosis, etc.). Particular focus will be done on the altered amino acid metabolism tightly linked to tumor outgrowth, metastasis, and therapeutic resistance.
Dr. Eleonora Vecchio
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- oncogenesis
- novel targeted therapy
- molecular mechanisms
- drug resistance
- cancer cell death
- amino acid metabolism
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.